Menarini Stemline logo

Menarini Stemline

600 employees · est. 2003 · New York, United States

VS
ViroCure logo

ViroCure

ViroCure is at the forefront of cancer therapeutics research and vaccine development with oncolytic virotherapy.

5 employees · est. 2016 · Seoul, Korea South

Menarini Stemline is the older company (2003 vs 2016); Menarini Stemline is the larger of the two.

Side-by-Side Comparison

Menarini Stemline ViroCure
Founded
2003 older 2016
Headquarters
New York, United States Seoul, Korea South
Employees
600 larger 5
Industry
Biotechnology, Health Care Health and Wellness
Funding Stage
Post Ipo Equity Series Unknown
Total Funding
$195.09M Not tracked yet
Funding Rounds
6 Not tracked yet
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Not tracked yet
Website
stemline.com virocure.net
Menarini Stemline logo

About Menarini Stemline

Menarini Stemline is a subsidiary of the Menarini Group, an influential Italian pharmaceutical and diagnostics company. It has a focus on revolutionizing oncology treatments for individuals living with cancer. Established in 2003, the company operates in the Biotechnology and Health Care sectors and...

ViroCure logo

About ViroCure

ViroCure is a pioneering company at the forefront of cancer therapeutics research and vaccine development with oncolytic virotherapy. The company is dedicated to discovering and developing unique viruses to safely and effectively treat various types of cancer illnesses with no current cure regimen....

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Menarini Stemline and ViroCure — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Menarini Stemline and ViroCure — by email.

Frequently Asked Questions

Menarini Stemline. ViroCure — ViroCure is at the forefront of cancer therapeutics research and vaccine development with oncolytic virotherapy.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Menarini Stemline has raised $195.09M while ViroCure has raised undisclosed funding.
Menarini Stemline and ViroCure operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Menarini Stemline with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy